

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 5.08962358 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 5.08962358 |
| 3 | L-amino acid import (GO:0043092) | 5.08840880 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.92872670 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 4.71150072 |
| 6 | presynaptic membrane assembly (GO:0097105) | 4.44825196 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.39921614 |
| 8 | vocalization behavior (GO:0071625) | 4.32970635 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.31671759 |
| 10 | amino acid import (GO:0043090) | 4.30125097 |
| 11 | cellular extravasation (GO:0045123) | 4.09887943 |
| 12 | presynaptic membrane organization (GO:0097090) | 4.09814579 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.07295280 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.04967259 |
| 15 | positive regulation by symbiont of host defense response (GO:0052509) | 4.01875979 |
| 16 | modulation by symbiont of host defense response (GO:0052031) | 4.01875979 |
| 17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.01875979 |
| 18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.01875979 |
| 19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.01875979 |
| 20 | modulation by symbiont of host immune response (GO:0052553) | 4.01875979 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.99629807 |
| 22 | negative regulation of cell killing (GO:0031342) | 3.99629807 |
| 23 | synaptic vesicle maturation (GO:0016188) | 3.93694628 |
| 24 | postsynaptic membrane organization (GO:0001941) | 3.89611210 |
| 25 | synaptic vesicle exocytosis (GO:0016079) | 3.83469217 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.79376726 |
| 27 | oxygen transport (GO:0015671) | 3.76585720 |
| 28 | protein localization to synapse (GO:0035418) | 3.74060288 |
| 29 | auditory behavior (GO:0031223) | 3.70668741 |
| 30 | glutamate secretion (GO:0014047) | 3.70484289 |
| 31 | negative regulation of neurotransmitter transport (GO:0051589) | 3.68039529 |
| 32 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.65323790 |
| 33 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.63520220 |
| 34 | dendritic spine morphogenesis (GO:0060997) | 3.56743555 |
| 35 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.56588106 |
| 36 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.55804011 |
| 37 | response to auditory stimulus (GO:0010996) | 3.55191084 |
| 38 | response to peptidoglycan (GO:0032494) | 3.55172155 |
| 39 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.53009760 |
| 40 | gas transport (GO:0015669) | 3.52487919 |
| 41 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.52456179 |
| 42 | neuronal action potential propagation (GO:0019227) | 3.48135810 |
| 43 | exploration behavior (GO:0035640) | 3.48028673 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 3.47925239 |
| 45 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.47589902 |
| 46 | fatty acid elongation (GO:0030497) | 3.45749586 |
| 47 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.43136554 |
| 48 | C4-dicarboxylate transport (GO:0015740) | 3.40496083 |
| 49 | glutamate receptor signaling pathway (GO:0007215) | 3.40494022 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.39544735 |
| 51 | neuron recognition (GO:0008038) | 3.39477282 |
| 52 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.38858609 |
| 53 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.38829127 |
| 54 | mechanosensory behavior (GO:0007638) | 3.34722467 |
| 55 | regulation of platelet aggregation (GO:0090330) | 3.34357251 |
| 56 | negative regulation of interleukin-12 production (GO:0032695) | 3.32323596 |
| 57 | long-term synaptic potentiation (GO:0060291) | 3.31205454 |
| 58 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.30711642 |
| 59 | regulation of synapse structural plasticity (GO:0051823) | 3.29779478 |
| 60 | macrophage activation involved in immune response (GO:0002281) | 3.29328999 |
| 61 | cerebellar granule cell differentiation (GO:0021707) | 3.29242571 |
| 62 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.29133276 |
| 63 | neurotransmitter uptake (GO:0001504) | 3.29085423 |
| 64 | transmission of nerve impulse (GO:0019226) | 3.28410671 |
| 65 | dendrite morphogenesis (GO:0048813) | 3.26531123 |
| 66 | axonal fasciculation (GO:0007413) | 3.26119135 |
| 67 | gamma-aminobutyric acid transport (GO:0015812) | 3.25497775 |
| 68 | neuron-neuron synaptic transmission (GO:0007270) | 3.21403739 |
| 69 | myelination (GO:0042552) | 3.21168433 |
| 70 | response to muramyl dipeptide (GO:0032495) | 3.17559325 |
| 71 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.16736610 |
| 72 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.16255864 |
| 73 | leukocyte aggregation (GO:0070486) | 3.14142799 |
| 74 | layer formation in cerebral cortex (GO:0021819) | 3.13714268 |
| 75 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.13063906 |
| 76 | ensheathment of neurons (GO:0007272) | 3.12541745 |
| 77 | axon ensheathment (GO:0008366) | 3.12541745 |
| 78 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.11207029 |
| 79 | establishment of mitochondrion localization (GO:0051654) | 3.10586756 |
| 80 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.10274218 |
| 81 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.09664143 |
| 82 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.09504108 |
| 83 | negative regulation of protein localization to cell surface (GO:2000009) | 3.09272598 |
| 84 | detection of other organism (GO:0098543) | 3.08438874 |
| 85 | erythrocyte development (GO:0048821) | 3.07529973 |
| 86 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.05954025 |
| 87 | modulation by symbiont of host cellular process (GO:0044068) | 3.04043390 |
| 88 | positive regulation of synapse assembly (GO:0051965) | 3.02228067 |
| 89 | response to protozoan (GO:0001562) | 2.99745576 |
| 90 | regulation of synaptic vesicle transport (GO:1902803) | 2.97725832 |
| 91 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.97706959 |
| 92 | signal complex assembly (GO:0007172) | 2.96781136 |
| 93 | defense response to protozoan (GO:0042832) | 2.96668968 |
| 94 | detection of bacterium (GO:0016045) | 2.95796825 |
| 95 | acidic amino acid transport (GO:0015800) | 2.94624081 |
| 96 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.94290300 |
| 97 | response to methylmercury (GO:0051597) | 2.92077491 |
| 98 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.91254941 |
| 99 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.91019393 |
| 100 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.90048969 |
| 101 | startle response (GO:0001964) | 2.89167224 |
| 102 | B cell receptor signaling pathway (GO:0050853) | 2.88587206 |
| 103 | germinal center formation (GO:0002467) | 2.88462022 |
| 104 | regulation of early endosome to late endosome transport (GO:2000641) | 2.88405947 |
| 105 | regulation of synaptic plasticity (GO:0048167) | 2.86973449 |
| 106 | positive thymic T cell selection (GO:0045059) | 2.86808350 |
| 107 | myeloid dendritic cell differentiation (GO:0043011) | 2.86609930 |
| 108 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.86426587 |
| 109 | regulation of mast cell degranulation (GO:0043304) | 2.85829483 |
| 110 | modulation by virus of host process (GO:0019054) | 2.84516721 |
| 111 | regulation of macrophage cytokine production (GO:0010935) | 2.83355125 |
| 112 | neurotransmitter secretion (GO:0007269) | 2.83193691 |
| 113 | synapse assembly (GO:0007416) | 2.82198516 |
| 114 | regulation of gamma-delta T cell activation (GO:0046643) | 2.81742669 |
| 115 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.81714652 |
| 116 | regulation of respiratory system process (GO:0044065) | 2.81312294 |
| 117 | cellular potassium ion homeostasis (GO:0030007) | 2.81140950 |
| 118 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.80909451 |
| 119 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.80208005 |
| 120 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.79277218 |
| 121 | L-glutamate transport (GO:0015813) | 2.77988043 |
| 122 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.77670236 |
| 123 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.76952929 |
| 124 | positive regulation of Rap GTPase activity (GO:0032854) | 2.76809467 |
| 125 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.76561039 |
| 126 | adenosine receptor signaling pathway (GO:0001973) | 2.75745711 |
| 127 | response to host immune response (GO:0052572) | 2.75649771 |
| 128 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.75649771 |
| 129 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.75125030 |
| 130 | positive regulation of macrophage cytokine production (GO:0060907) | 2.75062789 |
| 131 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.74440998 |
| 132 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.73871629 |
| 133 | long-term memory (GO:0007616) | 2.69944013 |
| 134 | regulation of postsynaptic membrane potential (GO:0060078) | 2.67685642 |
| 135 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.67095424 |
| 136 | oligodendrocyte differentiation (GO:0048709) | 2.66972984 |
| 137 | positive regulation of membrane potential (GO:0045838) | 2.66043445 |
| 138 | T-helper 1 type immune response (GO:0042088) | 2.65695662 |
| 139 | neuronal ion channel clustering (GO:0045161) | 2.65406403 |
| 140 | dendrite development (GO:0016358) | 2.64933739 |
| 141 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.62810472 |
| 142 | regulation of respiratory gaseous exchange (GO:0043576) | 2.62464890 |
| 143 | negative regulation of T cell mediated immunity (GO:0002710) | 2.62332201 |
| 144 | adult walking behavior (GO:0007628) | 2.61975721 |
| 145 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.61963562 |
| 146 | T cell migration (GO:0072678) | 2.61793560 |
| 147 | regulation of leukocyte degranulation (GO:0043300) | 2.60930940 |
| 148 | innervation (GO:0060384) | 2.60587200 |
| 149 | dendritic spine organization (GO:0097061) | 2.58859506 |
| 150 | neurotransmitter transport (GO:0006836) | 2.58602636 |
| 151 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.57637510 |
| 152 | regulation of neurotransmitter secretion (GO:0046928) | 2.57616899 |
| 153 | learning (GO:0007612) | 2.57514206 |
| 154 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.57314495 |
| 155 | response to type I interferon (GO:0034340) | 2.56780508 |
| 156 | regulation of T cell tolerance induction (GO:0002664) | 2.54945783 |
| 157 | myeloid dendritic cell activation (GO:0001773) | 2.54722056 |
| 158 | immunoglobulin mediated immune response (GO:0016064) | 2.54637900 |
| 159 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.54223522 |
| 160 | cellular response to type I interferon (GO:0071357) | 2.52777282 |
| 161 | type I interferon signaling pathway (GO:0060337) | 2.52777282 |
| 162 | regulation of neurotransmitter transport (GO:0051588) | 2.52344576 |
| 163 | peripheral nervous system axon ensheathment (GO:0032292) | 2.52292353 |
| 164 | myelination in peripheral nervous system (GO:0022011) | 2.52292353 |
| 165 | cell migration in hindbrain (GO:0021535) | 2.51196204 |
| 166 | response to laminar fluid shear stress (GO:0034616) | 2.50973352 |
| 167 | negative regulation of focal adhesion assembly (GO:0051895) | 2.50857618 |
| 168 | negative regulation of cell junction assembly (GO:1901889) | 2.50857618 |
| 169 | negative regulation of adherens junction organization (GO:1903392) | 2.50857618 |
| 170 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.50674028 |
| 171 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.50277331 |
| 172 | NIK/NF-kappaB signaling (GO:0038061) | 2.49448643 |
| 173 | neutrophil activation involved in immune response (GO:0002283) | 2.48498838 |
| 174 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.47880528 |
| 175 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.46817477 |
| 176 | detection of external biotic stimulus (GO:0098581) | 2.43665876 |
| 177 | response to host (GO:0075136) | 2.43062845 |
| 178 | response to host defenses (GO:0052200) | 2.43062845 |
| 179 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.43062845 |
| 180 | granulocyte differentiation (GO:0030851) | 2.42640362 |
| 181 | positive regulation of mast cell activation (GO:0033005) | 2.41396255 |
| 182 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.41359327 |
| 183 | regulation of response to osmotic stress (GO:0047484) | 2.41214847 |
| 184 | barbed-end actin filament capping (GO:0051016) | 2.41114379 |
| 185 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.41022465 |
| 186 | protein localization to endosome (GO:0036010) | 2.40653907 |
| 187 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.40197607 |
| 188 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.39928574 |
| 189 | regulation of ARF protein signal transduction (GO:0032012) | 2.38533200 |
| 190 | respiratory burst (GO:0045730) | 2.37819077 |
| 191 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.37717239 |
| 192 | regulation of regulated secretory pathway (GO:1903305) | 2.37681057 |
| 193 | microglial cell activation (GO:0001774) | 2.36227100 |
| 194 | thymic T cell selection (GO:0045061) | 2.34429209 |
| 195 | hemoglobin metabolic process (GO:0020027) | 2.32942699 |
| 196 | tolerance induction (GO:0002507) | 2.31794973 |
| 197 | macrophage activation (GO:0042116) | 2.31262173 |
| 198 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.30482034 |
| 199 | stress fiber assembly (GO:0043149) | 2.30418168 |
| 200 | regulation of tolerance induction (GO:0002643) | 2.29870949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.71879968 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.56278999 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.08253726 |
| 4 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.02285700 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.00393149 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.99664711 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.99516391 |
| 8 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.99144069 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.89428349 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.80530748 |
| 11 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62301537 |
| 12 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62301537 |
| 13 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.60451530 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.57980925 |
| 15 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.55357505 |
| 16 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54220581 |
| 17 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.53943916 |
| 18 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51292750 |
| 19 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.49481866 |
| 20 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.48601978 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.47084818 |
| 22 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.44090720 |
| 23 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.41386657 |
| 24 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.41108300 |
| 25 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.37205387 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.34824489 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.34475515 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.33480158 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.32844606 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.28897463 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.28681711 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.27931511 |
| 33 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.26656520 |
| 34 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.23357043 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.21236256 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20417401 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.19560908 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.17687803 |
| 39 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.16297473 |
| 40 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12004368 |
| 41 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10423919 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 2.00819401 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.99434129 |
| 44 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.98027879 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.97275418 |
| 46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96553555 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.95836837 |
| 48 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.92372266 |
| 49 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.91573767 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90304565 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90073778 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86338134 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.84223681 |
| 54 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83163280 |
| 55 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82567585 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.82134066 |
| 57 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.80193212 |
| 58 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.78584422 |
| 59 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.76799253 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76438692 |
| 61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75777227 |
| 62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.75470606 |
| 63 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.75114199 |
| 64 | UTX_26944678_Chip-Seq_JUKART_Human | 1.74137046 |
| 65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73336832 |
| 66 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.72290576 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70424269 |
| 68 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.70074098 |
| 69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69523038 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.69346871 |
| 71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68950179 |
| 72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68497891 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.68250730 |
| 74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.67727697 |
| 75 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.67630661 |
| 76 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.66794897 |
| 77 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.65506501 |
| 78 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.64958026 |
| 79 | P300_19829295_ChIP-Seq_ESCs_Human | 1.62877630 |
| 80 | MAF_26560356_Chip-Seq_TH2_Human | 1.61558279 |
| 81 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.56352056 |
| 82 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55824422 |
| 83 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.55467195 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.55279334 |
| 85 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54662039 |
| 86 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53688687 |
| 87 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51755984 |
| 88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.51182325 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.50657368 |
| 90 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50118107 |
| 91 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.47182234 |
| 92 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.45848101 |
| 93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45695117 |
| 94 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.44925782 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44834561 |
| 96 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44131834 |
| 97 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.43903439 |
| 98 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43471036 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41620696 |
| 100 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.40429976 |
| 101 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.39176985 |
| 102 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35467338 |
| 103 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.34507810 |
| 104 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.34193100 |
| 105 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32536860 |
| 106 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32524618 |
| 107 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.32406914 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31471639 |
| 109 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30967223 |
| 110 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30221229 |
| 111 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29911720 |
| 112 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27695895 |
| 113 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.27293973 |
| 114 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.26364171 |
| 115 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26246853 |
| 116 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.26042821 |
| 117 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26003431 |
| 118 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25161522 |
| 119 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23916125 |
| 120 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23625929 |
| 121 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23385376 |
| 122 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.23129097 |
| 123 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22910268 |
| 124 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.22552537 |
| 125 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22291782 |
| 126 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18632782 |
| 127 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18259230 |
| 128 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18109467 |
| 129 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17719151 |
| 130 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17416599 |
| 131 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17386276 |
| 132 | MYB_26560356_Chip-Seq_TH1_Human | 1.16845542 |
| 133 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16446279 |
| 134 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16155766 |
| 135 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.15783463 |
| 136 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15225394 |
| 137 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15178553 |
| 138 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.14871942 |
| 139 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.14386777 |
| 140 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13633134 |
| 141 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12583192 |
| 142 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12582791 |
| 143 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12214680 |
| 144 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10905349 |
| 145 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10775212 |
| 146 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.10462769 |
| 147 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.10443005 |
| 148 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08568699 |
| 149 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07739022 |
| 150 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07680983 |
| 151 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07566338 |
| 152 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07319083 |
| 153 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06945168 |
| 154 | AR_19668381_ChIP-Seq_PC3_Human | 1.06247792 |
| 155 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06155852 |
| 156 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.05932890 |
| 157 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04982977 |
| 158 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04982977 |
| 159 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.04581504 |
| 160 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03580454 |
| 161 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03503445 |
| 162 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03441870 |
| 163 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.02678419 |
| 164 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01321761 |
| 165 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.01301092 |
| 166 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.99755015 |
| 167 | P68_20966046_ChIP-Seq_HELA_Human | 0.99415869 |
| 168 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99330021 |
| 169 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99264893 |
| 170 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98868211 |
| 171 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98854647 |
| 172 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98493848 |
| 173 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.97806844 |
| 174 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97748221 |
| 175 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97608552 |
| 176 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97301851 |
| 177 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97024434 |
| 178 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96942000 |
| 179 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.96890010 |
| 180 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.96539351 |
| 181 | JUN_21703547_ChIP-Seq_K562_Human | 0.96486767 |
| 182 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95989417 |
| 183 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95977462 |
| 184 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95722134 |
| 185 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95039174 |
| 186 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94555985 |
| 187 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94061004 |
| 188 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94022271 |
| 189 | * MYB_26560356_Chip-Seq_TH2_Human | 0.93895611 |
| 190 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93261245 |
| 191 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.93212691 |
| 192 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.92533069 |
| 193 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92518354 |
| 194 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92398489 |
| 195 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.91620212 |
| 196 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91563297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.04559744 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.78825381 |
| 3 | MP0003880_abnormal_central_pattern | 3.98364237 |
| 4 | MP0003436_decreased_susceptibility_to | 3.42337326 |
| 5 | MP0004270_analgesia | 3.33692247 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.25158843 |
| 7 | MP0009278_abnormal_bone_marrow | 3.06122933 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.82139333 |
| 9 | MP0003656_abnormal_erythrocyte_physiolo | 2.79061072 |
| 10 | MP0001486_abnormal_startle_reflex | 2.78454800 |
| 11 | MP0009745_abnormal_behavioral_response | 2.77560017 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.74717710 |
| 13 | MP0002064_seizures | 2.68155148 |
| 14 | MP0000778_abnormal_nervous_system | 2.56864744 |
| 15 | MP0003724_increased_susceptibility_to | 2.54760983 |
| 16 | MP0004510_myositis | 2.54746597 |
| 17 | MP0000685_abnormal_immune_system | 2.54497633 |
| 18 | MP0001790_abnormal_immune_system | 2.50833379 |
| 19 | MP0005387_immune_system_phenotype | 2.50833379 |
| 20 | MP0002272_abnormal_nervous_system | 2.43681487 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.41049728 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 2.39797629 |
| 23 | MP0005671_abnormal_response_to | 2.38369901 |
| 24 | MP0009046_muscle_twitch | 2.37246200 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.35695733 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.33775512 |
| 27 | MP0005000_abnormal_immune_tolerance | 2.33272400 |
| 28 | MP0004885_abnormal_endolymph | 2.32855045 |
| 29 | MP0001835_abnormal_antigen_presentation | 2.32746978 |
| 30 | MP0005025_abnormal_response_to | 2.30607204 |
| 31 | MP0001968_abnormal_touch/_nociception | 2.26677190 |
| 32 | MP0001800_abnormal_humoral_immune | 2.26307457 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 2.26224710 |
| 34 | MP0009785_altered_susceptibility_to | 2.23908249 |
| 35 | MP0002419_abnormal_innate_immunity | 2.23840402 |
| 36 | MP0000920_abnormal_myelination | 2.14698835 |
| 37 | MP0004858_abnormal_nervous_system | 2.08305257 |
| 38 | MP0001545_abnormal_hematopoietic_system | 2.02023706 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 2.02023706 |
| 40 | MP0002723_abnormal_immune_serum | 2.00742473 |
| 41 | MP0002452_abnormal_antigen_presenting | 2.00610601 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.97128199 |
| 43 | MP0004947_skin_inflammation | 1.96663112 |
| 44 | MP0002736_abnormal_nociception_after | 1.95503236 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.93297641 |
| 46 | MP0003329_amyloid_beta_deposits | 1.91687530 |
| 47 | * MP0002420_abnormal_adaptive_immunity | 1.91588649 |
| 48 | MP0002735_abnormal_chemical_nociception | 1.91170313 |
| 49 | MP0008569_lethality_at_weaning | 1.90419429 |
| 50 | * MP0001819_abnormal_immune_cell | 1.89927892 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.89219393 |
| 52 | MP0009780_abnormal_chondrocyte_physiolo | 1.84521928 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.81855619 |
| 54 | MP0002067_abnormal_sensory_capabilities | 1.81714949 |
| 55 | MP0003075_altered_response_to | 1.81405508 |
| 56 | MP0003690_abnormal_glial_cell | 1.78567681 |
| 57 | MP0009764_decreased_sensitivity_to | 1.76896026 |
| 58 | MP0005409_darkened_coat_color | 1.75953113 |
| 59 | MP0001905_abnormal_dopamine_level | 1.75711145 |
| 60 | MP0001529_abnormal_vocalization | 1.74980502 |
| 61 | MP0001440_abnormal_grooming_behavior | 1.74737630 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.74611138 |
| 63 | MP0002398_abnormal_bone_marrow | 1.74254589 |
| 64 | MP0006082_CNS_inflammation | 1.74233635 |
| 65 | MP0005451_abnormal_body_composition | 1.74023303 |
| 66 | MP0002405_respiratory_system_inflammati | 1.70150979 |
| 67 | MP0000955_abnormal_spinal_cord | 1.69097898 |
| 68 | MP0001970_abnormal_pain_threshold | 1.69004901 |
| 69 | MP0005645_abnormal_hypothalamus_physiol | 1.68978502 |
| 70 | MP0008260_abnormal_autophagy | 1.68761257 |
| 71 | MP0004742_abnormal_vestibular_system | 1.68451875 |
| 72 | MP0003279_aneurysm | 1.68060623 |
| 73 | MP0002733_abnormal_thermal_nociception | 1.67462008 |
| 74 | MP0002822_catalepsy | 1.67424256 |
| 75 | MP0003091_abnormal_cell_migration | 1.66582240 |
| 76 | MP0003763_abnormal_thymus_physiology | 1.63915024 |
| 77 | MP0003634_abnormal_glial_cell | 1.61554545 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.61105843 |
| 79 | MP0002557_abnormal_social/conspecific_i | 1.58428217 |
| 80 | MP0002882_abnormal_neuron_morphology | 1.56025907 |
| 81 | MP0000716_abnormal_immune_system | 1.55004877 |
| 82 | MP0001485_abnormal_pinna_reflex | 1.53043270 |
| 83 | MP0005386_behavior/neurological_phenoty | 1.52236071 |
| 84 | MP0004924_abnormal_behavior | 1.52236071 |
| 85 | MP0005171_absent_coat_pigmentation | 1.51502194 |
| 86 | MP0001501_abnormal_sleep_pattern | 1.51312644 |
| 87 | MP0004142_abnormal_muscle_tone | 1.51033917 |
| 88 | MP0002184_abnormal_innervation | 1.50090377 |
| 89 | MP0009840_abnormal_foam_cell | 1.49074912 |
| 90 | MP0004147_increased_porphyrin_level | 1.48824207 |
| 91 | MP0003633_abnormal_nervous_system | 1.45684579 |
| 92 | MP0000343_altered_response_to | 1.40810684 |
| 93 | MP0002396_abnormal_hematopoietic_system | 1.39737078 |
| 94 | MP0002429_abnormal_blood_cell | 1.37743025 |
| 95 | MP0003631_nervous_system_phenotype | 1.35985228 |
| 96 | MP0008874_decreased_physiological_sensi | 1.35180858 |
| 97 | MP0002722_abnormal_immune_system | 1.33280562 |
| 98 | MP0006276_abnormal_autonomic_nervous | 1.32750622 |
| 99 | MP0002066_abnormal_motor_capabilities/c | 1.32179079 |
| 100 | MP0004811_abnormal_neuron_physiology | 1.31914212 |
| 101 | MP0001984_abnormal_olfaction | 1.30183761 |
| 102 | MP0003136_yellow_coat_color | 1.29800658 |
| 103 | MP0001188_hyperpigmentation | 1.29360496 |
| 104 | MP0005310_abnormal_salivary_gland | 1.28438835 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 1.27457427 |
| 106 | MP0001502_abnormal_circadian_rhythm | 1.27264520 |
| 107 | MP0010155_abnormal_intestine_physiology | 1.23075264 |
| 108 | MP0002009_preneoplasia | 1.22971752 |
| 109 | MP0002152_abnormal_brain_morphology | 1.22347190 |
| 110 | MP0001845_abnormal_inflammatory_respons | 1.21934536 |
| 111 | MP0003632_abnormal_nervous_system | 1.19897406 |
| 112 | MP0005551_abnormal_eye_electrophysiolog | 1.19643894 |
| 113 | MP0005166_decreased_susceptibility_to | 1.18193647 |
| 114 | MP0001963_abnormal_hearing_physiology | 1.18081673 |
| 115 | MP0000703_abnormal_thymus_morphology | 1.17896345 |
| 116 | MP0000689_abnormal_spleen_morphology | 1.17791304 |
| 117 | MP0003122_maternal_imprinting | 1.17576836 |
| 118 | MP0003448_altered_tumor_morphology | 1.17478601 |
| 119 | MP0005164_abnormal_response_to | 1.16464743 |
| 120 | MP0001299_abnormal_eye_distance/ | 1.15181814 |
| 121 | MP0003045_fibrosis | 1.14820571 |
| 122 | MP0004134_abnormal_chest_morphology | 1.14525277 |
| 123 | MP0005623_abnormal_meninges_morphology | 1.13739440 |
| 124 | MP0009250_abnormal_appendicular_skeleto | 1.12475005 |
| 125 | MP0003191_abnormal_cellular_cholesterol | 1.11577517 |
| 126 | MP0003172_abnormal_lysosome_physiology | 1.11356654 |
| 127 | MP0005275_abnormal_skin_tensile | 1.10703605 |
| 128 | MP0005390_skeleton_phenotype | 1.10282742 |
| 129 | MP0005076_abnormal_cell_differentiation | 1.09962426 |
| 130 | MP0002229_neurodegeneration | 1.09878996 |
| 131 | MP0002752_abnormal_somatic_nervous | 1.09226414 |
| 132 | MP0001177_atelectasis | 1.09065066 |
| 133 | MP0005058_abnormal_lysosome_morphology | 1.08946821 |
| 134 | MP0000026_abnormal_inner_ear | 1.06842762 |
| 135 | MP0004808_abnormal_hematopoietic_stem | 1.06045748 |
| 136 | MP0000858_altered_metastatic_potential | 1.04751980 |
| 137 | MP0000631_abnormal_neuroendocrine_gland | 1.04028790 |
| 138 | MP0003828_pulmonary_edema | 1.02615980 |
| 139 | MP0005503_abnormal_tendon_morphology | 1.01958383 |
| 140 | MP0003183_abnormal_peptide_metabolism | 1.01206676 |
| 141 | MP0008469_abnormal_protein_level | 1.00059912 |
| 142 | MP0003938_abnormal_ear_development | 0.99738244 |
| 143 | MP0000767_abnormal_smooth_muscle | 0.98849445 |
| 144 | MP0001851_eye_inflammation | 0.94710747 |
| 145 | MP0001664_abnormal_digestion | 0.91583242 |
| 146 | MP0001663_abnormal_digestive_system | 0.91328374 |
| 147 | MP0008004_abnormal_stomach_pH | 0.90925955 |
| 148 | MP0005394_taste/olfaction_phenotype | 0.87799162 |
| 149 | MP0005499_abnormal_olfactory_system | 0.87799162 |
| 150 | MP0000566_synostosis | 0.87658417 |
| 151 | MP0000049_abnormal_middle_ear | 0.87444905 |
| 152 | MP0005023_abnormal_wound_healing | 0.86169004 |
| 153 | MP0005167_abnormal_blood-brain_barrier | 0.85041133 |
| 154 | MP0004272_abnormal_basement_membrane | 0.84469388 |
| 155 | MP0003795_abnormal_bone_structure | 0.84306168 |
| 156 | MP0002933_joint_inflammation | 0.82997926 |
| 157 | MP0005381_digestive/alimentary_phenotyp | 0.82730842 |
| 158 | MP0001958_emphysema | 0.82563823 |
| 159 | MP0003879_abnormal_hair_cell | 0.79719692 |
| 160 | MP0009763_increased_sensitivity_to | 0.79385515 |
| 161 | MP0003861_abnormal_nervous_system | 0.79315485 |
| 162 | MP0003787_abnormal_imprinting | 0.78645236 |
| 163 | MP0002090_abnormal_vision | 0.75802739 |
| 164 | MP0000534_abnormal_ureter_morphology | 0.75606356 |
| 165 | MP0002069_abnormal_eating/drinking_beha | 0.74764251 |
| 166 | MP0002249_abnormal_larynx_morphology | 0.74749105 |
| 167 | MP0001849_ear_inflammation | 0.74381364 |
| 168 | MP0003385_abnormal_body_wall | 0.74230076 |
| 169 | MP0000249_abnormal_blood_vessel | 0.74229560 |
| 170 | MP0005195_abnormal_posterior_eye | 0.73633913 |
| 171 | MP0003566_abnormal_cell_adhesion | 0.71964673 |
| 172 | MP0001986_abnormal_taste_sensitivity | 0.71139454 |
| 173 | MP0001943_abnormal_respiration | 0.71099841 |
| 174 | MP0003942_abnormal_urinary_system | 0.70842175 |
| 175 | MP0000604_amyloidosis | 0.70585519 |
| 176 | MP0001853_heart_inflammation | 0.70442133 |
| 177 | MP0004145_abnormal_muscle_electrophysio | 0.70412213 |
| 178 | MP0000465_gastrointestinal_hemorrhage | 0.69631036 |
| 179 | MP0004883_abnormal_blood_vessel | 0.68870021 |
| 180 | MP0002233_abnormal_nose_morphology | 0.67125024 |
| 181 | MP0006292_abnormal_olfactory_placode | 0.66385437 |
| 182 | MP0003868_abnormal_feces_composition | 0.63853428 |
| 183 | MP0008789_abnormal_olfactory_epithelium | 0.63840028 |
| 184 | MP0004085_abnormal_heartbeat | 0.63180090 |
| 185 | MP0003950_abnormal_plasma_membrane | 0.62702800 |
| 186 | MP0002638_abnormal_pupillary_reflex | 0.61454776 |
| 187 | MP0005253_abnormal_eye_physiology | 0.60386424 |
| 188 | MP0003755_abnormal_palate_morphology | 0.59663625 |
| 189 | MP0003937_abnormal_limbs/digits/tail_de | 0.58514321 |
| 190 | MP0005595_abnormal_vascular_smooth | 0.57643030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.23437404 |
| 2 | Myokymia (HP:0002411) | 4.82682890 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.46671952 |
| 4 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.43914157 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.40593437 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.18463252 |
| 7 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.16363421 |
| 8 | Aplasia of the phalanges of the hand (HP:0009802) | 4.16363421 |
| 9 | Aplasia involving bones of the extremities (HP:0009825) | 4.16363421 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 4.01777587 |
| 11 | Megalencephaly (HP:0001355) | 4.00151315 |
| 12 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.78410909 |
| 13 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.78410909 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.67236915 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.61814576 |
| 16 | Focal seizures (HP:0007359) | 3.51651703 |
| 17 | Polycythemia (HP:0001901) | 3.47134647 |
| 18 | Action tremor (HP:0002345) | 3.46874394 |
| 19 | Termporal pattern (HP:0011008) | 3.45259597 |
| 20 | Insidious onset (HP:0003587) | 3.45259597 |
| 21 | Hyperventilation (HP:0002883) | 3.37599820 |
| 22 | Abnormality of the corticospinal tract (HP:0002492) | 3.31985474 |
| 23 | Progressive cerebellar ataxia (HP:0002073) | 3.25128573 |
| 24 | Cellulitis (HP:0100658) | 3.22591775 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.09496504 |
| 26 | Gastrointestinal stroma tumor (HP:0100723) | 3.07312909 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 3.03990528 |
| 28 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01572394 |
| 29 | Obstructive lung disease (HP:0006536) | 3.01572394 |
| 30 | Mediastinal lymphadenopathy (HP:0100721) | 2.90046206 |
| 31 | Retinal dysplasia (HP:0007973) | 2.89567404 |
| 32 | Ankle clonus (HP:0011448) | 2.88143358 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 2.87469279 |
| 34 | Febrile seizures (HP:0002373) | 2.87118433 |
| 35 | Spontaneous hematomas (HP:0007420) | 2.81573710 |
| 36 | Peripheral hypomyelination (HP:0007182) | 2.77966787 |
| 37 | Microcytic anemia (HP:0001935) | 2.75294229 |
| 38 | Broad-based gait (HP:0002136) | 2.75138673 |
| 39 | Atonic seizures (HP:0010819) | 2.74463185 |
| 40 | Cerebral aneurysm (HP:0004944) | 2.73646480 |
| 41 | Recurrent viral infections (HP:0004429) | 2.73483385 |
| 42 | Pheochromocytoma (HP:0002666) | 2.69990112 |
| 43 | Increased IgE level (HP:0003212) | 2.65672173 |
| 44 | Reticulocytosis (HP:0001923) | 2.64532921 |
| 45 | Dysdiadochokinesis (HP:0002075) | 2.64188041 |
| 46 | Emphysema (HP:0002097) | 2.63624442 |
| 47 | Meningitis (HP:0001287) | 2.63407906 |
| 48 | Poikilocytosis (HP:0004447) | 2.62311209 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61816072 |
| 50 | Myositis (HP:0100614) | 2.60732955 |
| 51 | Abnormal eating behavior (HP:0100738) | 2.60669761 |
| 52 | Recurrent fungal infections (HP:0002841) | 2.58723446 |
| 53 | Scanning speech (HP:0002168) | 2.53685093 |
| 54 | Orchitis (HP:0100796) | 2.53421858 |
| 55 | Dysmetria (HP:0001310) | 2.53381843 |
| 56 | Hemiparesis (HP:0001269) | 2.52347823 |
| 57 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.51165198 |
| 58 | Recurrent skin infections (HP:0001581) | 2.49393588 |
| 59 | Increased serum ferritin (HP:0003281) | 2.45765257 |
| 60 | Obstructive sleep apnea (HP:0002870) | 2.45500874 |
| 61 | Fibular aplasia (HP:0002990) | 2.44729796 |
| 62 | Truncal ataxia (HP:0002078) | 2.44345886 |
| 63 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.42701577 |
| 64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.42701577 |
| 65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.42701577 |
| 66 | Spastic gait (HP:0002064) | 2.40576092 |
| 67 | Diplopia (HP:0000651) | 2.38541384 |
| 68 | Abnormality of binocular vision (HP:0011514) | 2.38541384 |
| 69 | Vasculitis (HP:0002633) | 2.37641271 |
| 70 | Generalized tonic-clonic seizures (HP:0002069) | 2.37103186 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 2.36766808 |
| 72 | Optic neuritis (HP:0100653) | 2.36766808 |
| 73 | Slender build (HP:0001533) | 2.36247036 |
| 74 | Hypertensive crisis (HP:0100735) | 2.35574228 |
| 75 | Hypochromic microcytic anemia (HP:0004840) | 2.34465318 |
| 76 | Clumsiness (HP:0002312) | 2.31770045 |
| 77 | Prolonged bleeding time (HP:0003010) | 2.30318221 |
| 78 | Abnormal hemoglobin (HP:0011902) | 2.29914289 |
| 79 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.29403700 |
| 80 | Agammaglobulinemia (HP:0004432) | 2.27205033 |
| 81 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.25886285 |
| 82 | Neuroendocrine neoplasm (HP:0100634) | 2.24746502 |
| 83 | Anxiety (HP:0000739) | 2.24705246 |
| 84 | Genu recurvatum (HP:0002816) | 2.23088786 |
| 85 | Dialeptic seizures (HP:0011146) | 2.21928448 |
| 86 | Slow saccadic eye movements (HP:0000514) | 2.21585176 |
| 87 | Absence seizures (HP:0002121) | 2.21158774 |
| 88 | Lower limb muscle weakness (HP:0007340) | 2.20633599 |
| 89 | Gingivitis (HP:0000230) | 2.20061154 |
| 90 | Osteomyelitis (HP:0002754) | 2.16905795 |
| 91 | Urticaria (HP:0001025) | 2.16773694 |
| 92 | Lymphopenia (HP:0001888) | 2.15727302 |
| 93 | Narrow nasal bridge (HP:0000446) | 2.15698653 |
| 94 | Intention tremor (HP:0002080) | 2.15506410 |
| 95 | Gaze-evoked nystagmus (HP:0000640) | 2.13620705 |
| 96 | Hypochromic anemia (HP:0001931) | 2.13001405 |
| 97 | Colitis (HP:0002583) | 2.11071811 |
| 98 | Visual hallucinations (HP:0002367) | 2.11065905 |
| 99 | Dilatation of the ascending aorta (HP:0005111) | 2.10797969 |
| 100 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.10739897 |
| 101 | Viral hepatitis (HP:0006562) | 2.10095141 |
| 102 | Increased variability in muscle fiber diameter (HP:0003557) | 2.09388476 |
| 103 | Polyphagia (HP:0002591) | 2.09319678 |
| 104 | Chronic otitis media (HP:0000389) | 2.08570747 |
| 105 | Premature rupture of membranes (HP:0001788) | 2.07259091 |
| 106 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.05809760 |
| 107 | Epileptiform EEG discharges (HP:0011182) | 2.05247769 |
| 108 | Abnormality of iron homeostasis (HP:0011031) | 2.04997700 |
| 109 | Excessive salivation (HP:0003781) | 2.04988471 |
| 110 | Drooling (HP:0002307) | 2.04988471 |
| 111 | Coronal craniosynostosis (HP:0004440) | 2.04706559 |
| 112 | Humeroradial synostosis (HP:0003041) | 2.04603530 |
| 113 | Synostosis involving the elbow (HP:0003938) | 2.04603530 |
| 114 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.03527936 |
| 115 | Broad metatarsal (HP:0001783) | 2.03153283 |
| 116 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.02937452 |
| 117 | Thickened helices (HP:0000391) | 2.02606613 |
| 118 | Abnormality of the nasal mucosa (HP:0000433) | 2.00049644 |
| 119 | EEG with generalized epileptiform discharges (HP:0011198) | 1.98546664 |
| 120 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98297602 |
| 121 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98297602 |
| 122 | Urinary urgency (HP:0000012) | 1.98159585 |
| 123 | Hypoplastic left heart (HP:0004383) | 1.97427560 |
| 124 | Autoimmune thrombocytopenia (HP:0001973) | 1.97226291 |
| 125 | Restrictive lung disease (HP:0002091) | 1.97072970 |
| 126 | Encephalitis (HP:0002383) | 1.96657130 |
| 127 | Myelomeningocele (HP:0002475) | 1.96535557 |
| 128 | Peritonitis (HP:0002586) | 1.95194129 |
| 129 | Pulmonary infiltrates (HP:0002113) | 1.95090296 |
| 130 | Polygenic inheritance (HP:0010982) | 1.94133028 |
| 131 | Stomatitis (HP:0010280) | 1.93767327 |
| 132 | Depression (HP:0000716) | 1.92977427 |
| 133 | Poor eye contact (HP:0000817) | 1.92925897 |
| 134 | Hypsarrhythmia (HP:0002521) | 1.92756528 |
| 135 | Subacute progressive viral hepatitis (HP:0006572) | 1.92607199 |
| 136 | Abnormality of reticulocytes (HP:0004312) | 1.90460868 |
| 137 | Onion bulb formation (HP:0003383) | 1.90446616 |
| 138 | Keratoconjunctivitis sicca (HP:0001097) | 1.89568830 |
| 139 | Insomnia (HP:0100785) | 1.88321623 |
| 140 | Recurrent lower respiratory tract infections (HP:0002783) | 1.87397530 |
| 141 | Epistaxis (HP:0000421) | 1.87192818 |
| 142 | Morphological abnormality of the inner ear (HP:0011390) | 1.86971841 |
| 143 | Hypercortisolism (HP:0001578) | 1.86032889 |
| 144 | Alacrima (HP:0000522) | 1.85975845 |
| 145 | Absent speech (HP:0001344) | 1.83974750 |
| 146 | Blue irides (HP:0000635) | 1.83934079 |
| 147 | Diaphragmatic weakness (HP:0009113) | 1.83907796 |
| 148 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.83512871 |
| 149 | Cutaneous finger syndactyly (HP:0010554) | 1.81806117 |
| 150 | Gait imbalance (HP:0002141) | 1.81515651 |
| 151 | Relative macrocephaly (HP:0004482) | 1.81444264 |
| 152 | Akinesia (HP:0002304) | 1.81335334 |
| 153 | Papilloma (HP:0012740) | 1.81238418 |
| 154 | Verrucae (HP:0200043) | 1.81238418 |
| 155 | Genetic anticipation (HP:0003743) | 1.80558559 |
| 156 | Increased circulating renin level (HP:0000848) | 1.80542994 |
| 157 | Stereotypic behavior (HP:0000733) | 1.79553944 |
| 158 | Abnormality of the fingertips (HP:0001211) | 1.79234378 |
| 159 | Limb dystonia (HP:0002451) | 1.78667970 |
| 160 | Generalized myoclonic seizures (HP:0002123) | 1.78389168 |
| 161 | Parakeratosis (HP:0001036) | 1.77562646 |
| 162 | Buphthalmos (HP:0000557) | 1.76985451 |
| 163 | Abnormal platelet function (HP:0011869) | 1.76737365 |
| 164 | Impaired platelet aggregation (HP:0003540) | 1.76737365 |
| 165 | Postural instability (HP:0002172) | 1.75605308 |
| 166 | Split foot (HP:0001839) | 1.74759153 |
| 167 | Arthralgia (HP:0002829) | 1.74283896 |
| 168 | Gastrointestinal inflammation (HP:0004386) | 1.74018195 |
| 169 | Petechiae (HP:0000967) | 1.73193468 |
| 170 | Nasal polyposis (HP:0100582) | 1.73173493 |
| 171 | Generalized hypotonia (HP:0001290) | 1.72851312 |
| 172 | Hemiplegia (HP:0002301) | 1.72306697 |
| 173 | Impaired social interactions (HP:0000735) | 1.71750028 |
| 174 | Abnormal social behavior (HP:0012433) | 1.71750028 |
| 175 | Hemoptysis (HP:0002105) | 1.71357490 |
| 176 | Fetal akinesia sequence (HP:0001989) | 1.70887095 |
| 177 | Migraine (HP:0002076) | 1.70680399 |
| 178 | Overgrowth (HP:0001548) | 1.70605200 |
| 179 | Vaginal atresia (HP:0000148) | 1.69694858 |
| 180 | Paralysis (HP:0003470) | 1.68320052 |
| 181 | Turricephaly (HP:0000262) | 1.67904123 |
| 182 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.67832354 |
| 183 | Disproportionate tall stature (HP:0001519) | 1.67764409 |
| 184 | Purpura (HP:0000979) | 1.67597298 |
| 185 | Genital tract atresia (HP:0001827) | 1.67184005 |
| 186 | Meningocele (HP:0002435) | 1.67120263 |
| 187 | Specific learning disability (HP:0001328) | 1.65331248 |
| 188 | Mixed hearing impairment (HP:0000410) | 1.64283920 |
| 189 | Amblyopia (HP:0000646) | 1.64190122 |
| 190 | Short tibia (HP:0005736) | 1.63656906 |
| 191 | Ulnar claw (HP:0001178) | 1.62964982 |
| 192 | Morphological abnormality of the middle ear (HP:0008609) | 1.62460209 |
| 193 | Cutaneous syndactyly (HP:0012725) | 1.61931140 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.72983290 |
| 2 | RIPK4 | 4.20599593 |
| 3 | EPHA4 | 3.59801541 |
| 4 | NTRK3 | 3.21910405 |
| 5 | MARK1 | 3.05860646 |
| 6 | PRPF4B | 3.05054497 |
| 7 | MAP4K1 | 2.98214458 |
| 8 | MAP3K13 | 2.77668626 |
| 9 | NTRK2 | 2.54894070 |
| 10 | ERN1 | 2.52649377 |
| 11 | STK39 | 2.52590931 |
| 12 | TNIK | 2.27779794 |
| 13 | TRIB3 | 2.13992046 |
| 14 | MAP2K7 | 2.08147402 |
| 15 | MINK1 | 2.04778016 |
| 16 | MAP3K10 | 1.98293408 |
| 17 | MAP3K4 | 1.92162226 |
| 18 | TAOK2 | 1.87127554 |
| 19 | SGK494 | 1.80749011 |
| 20 | SGK223 | 1.80749011 |
| 21 | OXSR1 | 1.79400769 |
| 22 | IRAK3 | 1.79148524 |
| 23 | TYK2 | 1.74611007 |
| 24 | MAP2K3 | 1.72641360 |
| 25 | IRAK4 | 1.70819785 |
| 26 | MAPK13 | 1.70627257 |
| 27 | SMG1 | 1.70123443 |
| 28 | PHKG1 | 1.66517298 |
| 29 | PHKG2 | 1.66517298 |
| 30 | PLK2 | 1.66017603 |
| 31 | BLK | 1.63231114 |
| 32 | CSK | 1.61877355 |
| 33 | MAP3K14 | 1.59650801 |
| 34 | PAK6 | 1.58455368 |
| 35 | NTRK1 | 1.50695824 |
| 36 | EPHB1 | 1.49665799 |
| 37 | CDK5 | 1.41198218 |
| 38 | PDGFRA | 1.38995310 |
| 39 | MAPKAPK5 | 1.38633327 |
| 40 | PKN1 | 1.35529805 |
| 41 | MAP3K11 | 1.34219111 |
| 42 | UHMK1 | 1.32733868 |
| 43 | SGK2 | 1.32626775 |
| 44 | PRKD3 | 1.30001383 |
| 45 | CDK19 | 1.29928313 |
| 46 | MAP3K9 | 1.28790120 |
| 47 | IKBKE | 1.28049694 |
| 48 | ZAP70 | 1.26861790 |
| 49 | ARAF | 1.23543240 |
| 50 | JAK3 | 1.22511441 |
| 51 | RIPK1 | 1.22109728 |
| 52 | TAOK1 | 1.19387571 |
| 53 | BCR | 1.18544567 |
| 54 | MATK | 1.16399867 |
| 55 | TYRO3 | 1.14976505 |
| 56 | SYK | 1.14599298 |
| 57 | MAP3K3 | 1.14245391 |
| 58 | MAP3K1 | 1.11978076 |
| 59 | CDC42BPA | 1.11753033 |
| 60 | MUSK | 1.11116701 |
| 61 | TBK1 | 1.09333293 |
| 62 | DYRK1A | 1.08780875 |
| 63 | CAMK2A | 1.08740212 |
| 64 | NME2 | 1.07830779 |
| 65 | FGFR2 | 1.06317630 |
| 66 | NEK6 | 1.06086479 |
| 67 | WNK4 | 1.05572764 |
| 68 | KIT | 1.04164469 |
| 69 | DAPK2 | 1.04014218 |
| 70 | ROCK2 | 1.03788881 |
| 71 | PNCK | 1.03559910 |
| 72 | MOS | 1.01425121 |
| 73 | PRKCG | 1.01173288 |
| 74 | CLK1 | 0.98870645 |
| 75 | SIK1 | 0.98687908 |
| 76 | BTK | 0.98682343 |
| 77 | GRK6 | 0.96430764 |
| 78 | JAK1 | 0.95719951 |
| 79 | KSR1 | 0.94897270 |
| 80 | WNK1 | 0.93766665 |
| 81 | SGK3 | 0.92426643 |
| 82 | CAMKK1 | 0.92086093 |
| 83 | CDK14 | 0.91777289 |
| 84 | LYN | 0.91598893 |
| 85 | SIK2 | 0.89915940 |
| 86 | DYRK2 | 0.89907748 |
| 87 | FES | 0.88607739 |
| 88 | CDK18 | 0.86858118 |
| 89 | LMTK2 | 0.86573502 |
| 90 | PAK3 | 0.86415757 |
| 91 | CAMK2B | 0.85032345 |
| 92 | BMX | 0.84564615 |
| 93 | CDK15 | 0.83861238 |
| 94 | MAP2K4 | 0.83097707 |
| 95 | MKNK2 | 0.82226907 |
| 96 | RAF1 | 0.81958498 |
| 97 | PRKCE | 0.81321520 |
| 98 | MARK2 | 0.80343684 |
| 99 | RPS6KL1 | 0.79639178 |
| 100 | RPS6KC1 | 0.79639178 |
| 101 | JAK2 | 0.78481367 |
| 102 | TLK1 | 0.78314067 |
| 103 | HCK | 0.78196175 |
| 104 | PIM1 | 0.76687374 |
| 105 | PRKD2 | 0.76665634 |
| 106 | DDR2 | 0.75839199 |
| 107 | FGR | 0.73003484 |
| 108 | CDK11A | 0.72881571 |
| 109 | PRKCH | 0.72846670 |
| 110 | MAPK7 | 0.71876924 |
| 111 | CSNK1G2 | 0.71825360 |
| 112 | MAP3K8 | 0.70897501 |
| 113 | SGK1 | 0.70601912 |
| 114 | GRK5 | 0.69765297 |
| 115 | MKNK1 | 0.69453956 |
| 116 | CDK12 | 0.68434985 |
| 117 | TXK | 0.67431927 |
| 118 | IKBKB | 0.67003499 |
| 119 | RPS6KA2 | 0.65767023 |
| 120 | BMPR2 | 0.65194059 |
| 121 | PINK1 | 0.65164291 |
| 122 | BRAF | 0.63964754 |
| 123 | EEF2K | 0.63723379 |
| 124 | RPS6KA6 | 0.63456623 |
| 125 | TAOK3 | 0.63382498 |
| 126 | NME1 | 0.63290977 |
| 127 | PTK6 | 0.63137615 |
| 128 | KSR2 | 0.62758113 |
| 129 | PDGFRB | 0.62428489 |
| 130 | MAP3K12 | 0.61537495 |
| 131 | CAMK1 | 0.60918282 |
| 132 | HIPK2 | 0.60663133 |
| 133 | BMPR1B | 0.59829675 |
| 134 | MAPK12 | 0.59760452 |
| 135 | LATS2 | 0.58645936 |
| 136 | MAPK4 | 0.58145254 |
| 137 | ROCK1 | 0.56312379 |
| 138 | TNK2 | 0.55937927 |
| 139 | CAMK1G | 0.55910278 |
| 140 | FER | 0.55852426 |
| 141 | CAMK2D | 0.55564654 |
| 142 | PTK2B | 0.54878925 |
| 143 | PIK3CA | 0.53850610 |
| 144 | ADRBK1 | 0.53112326 |
| 145 | IRAK2 | 0.53072485 |
| 146 | PDK1 | 0.51161116 |
| 147 | LCK | 0.50171053 |
| 148 | STK11 | 0.50121836 |
| 149 | PRKCQ | 0.48156344 |
| 150 | MARK3 | 0.47861987 |
| 151 | PDPK1 | 0.47760088 |
| 152 | FGFR4 | 0.47485555 |
| 153 | DYRK3 | 0.47346576 |
| 154 | CHUK | 0.46712341 |
| 155 | AKT3 | 0.46701359 |
| 156 | CSNK1A1L | 0.46662830 |
| 157 | PRKG1 | 0.46537546 |
| 158 | SIK3 | 0.46220088 |
| 159 | CDK3 | 0.45475979 |
| 160 | CSF1R | 0.44708366 |
| 161 | CAMK2G | 0.44062882 |
| 162 | FYN | 0.42562373 |
| 163 | CSNK1G3 | 0.42322215 |
| 164 | EPHA3 | 0.42073760 |
| 165 | RPS6KA3 | 0.41479774 |
| 166 | RET | 0.41445252 |
| 167 | TGFBR2 | 0.41414819 |
| 168 | DMPK | 0.40898766 |
| 169 | ERBB3 | 0.40631296 |
| 170 | CSNK1A1 | 0.40628453 |
| 171 | MAPK10 | 0.40390574 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.96468501 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.80379827 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.57112722 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.45671780 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.44874740 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.40481712 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.36094843 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.26046515 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.24637682 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.21488007 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.19918352 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.15103423 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.13059681 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 2.11953684 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 2.09935623 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.98849918 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.88330238 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.85680407 |
| 19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.78457687 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.77783886 |
| 21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.73157260 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.70402322 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.67621613 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67220784 |
| 25 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.67011275 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65873328 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65335564 |
| 28 | Axon guidance_Homo sapiens_hsa04360 | 1.63471588 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61246086 |
| 30 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.60322017 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56557621 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54287756 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.51461501 |
| 34 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51346349 |
| 35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.50525775 |
| 36 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.50224621 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50054547 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.49765180 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 1.46825942 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.45900465 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.45011757 |
| 42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.44756251 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.42116245 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.41353266 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.37733220 |
| 46 | Taste transduction_Homo sapiens_hsa04742 | 1.37061907 |
| 47 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.35922471 |
| 48 | Renin secretion_Homo sapiens_hsa04924 | 1.32919253 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.32666295 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.31364772 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.30891650 |
| 52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.29910169 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29024350 |
| 54 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.28915569 |
| 55 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.28301374 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28093041 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.27174913 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.26363229 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.26271091 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.25900549 |
| 61 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24939371 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.22479770 |
| 63 | Gap junction_Homo sapiens_hsa04540 | 1.21664674 |
| 64 | Prion diseases_Homo sapiens_hsa05020 | 1.21658913 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 1.21141066 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 1.20717842 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.20669644 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.20041267 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19043358 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18817346 |
| 71 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.17965365 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.15553158 |
| 73 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15208427 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 1.14950357 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.14618377 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.13921933 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.12553288 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12340141 |
| 79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.11341209 |
| 80 | Asthma_Homo sapiens_hsa05310 | 1.09535891 |
| 81 | Measles_Homo sapiens_hsa05162 | 1.08022458 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 1.04782277 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 1.03313876 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.01847416 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01315369 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01024055 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00822046 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.00313229 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.99835735 |
| 90 | Amoebiasis_Homo sapiens_hsa05146 | 0.98132671 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.97418109 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96460400 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.95715515 |
| 94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95598815 |
| 95 | Glioma_Homo sapiens_hsa05214 | 0.94910959 |
| 96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94568390 |
| 97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.93005630 |
| 98 | Phagosome_Homo sapiens_hsa04145 | 0.91889447 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91558552 |
| 100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91365735 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89368759 |
| 102 | Phototransduction_Homo sapiens_hsa04744 | 0.89346377 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.89025433 |
| 104 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.88751819 |
| 105 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88395136 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87928602 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.86828353 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85513028 |
| 109 | Legionellosis_Homo sapiens_hsa05134 | 0.84892803 |
| 110 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.84513818 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.84471953 |
| 112 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83294357 |
| 113 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82168919 |
| 114 | Platelet activation_Homo sapiens_hsa04611 | 0.82122776 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81331224 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80359857 |
| 117 | Salmonella infection_Homo sapiens_hsa05132 | 0.79592451 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.79543204 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.79122472 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79040802 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.77604344 |
| 122 | Prostate cancer_Homo sapiens_hsa05215 | 0.75881929 |
| 123 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.75656342 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75002694 |
| 125 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73829370 |
| 126 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73804157 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73601916 |
| 128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72771237 |
| 129 | Shigellosis_Homo sapiens_hsa05131 | 0.72522557 |
| 130 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.71431061 |
| 131 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.69653777 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67798914 |
| 133 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66574521 |
| 134 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.66354037 |
| 135 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65529073 |
| 136 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64357211 |
| 137 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63155790 |
| 138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61823432 |
| 139 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60966302 |
| 140 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60058140 |
| 141 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59966585 |
| 142 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59471431 |
| 143 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57783693 |
| 144 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56907428 |
| 145 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.56700185 |
| 146 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55604813 |
| 147 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55446965 |
| 148 | Tight junction_Homo sapiens_hsa04530 | 0.54779981 |
| 149 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54234025 |
| 150 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54056575 |
| 151 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53856670 |
| 152 | Lysosome_Homo sapiens_hsa04142 | 0.53812525 |
| 153 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53628505 |
| 154 | Melanoma_Homo sapiens_hsa05218 | 0.53514878 |
| 155 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52701459 |
| 156 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52598712 |
| 157 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51737356 |
| 158 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.51660078 |
| 159 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51237910 |
| 160 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49332256 |
| 161 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47379482 |
| 162 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43028546 |
| 163 | Endocytosis_Homo sapiens_hsa04144 | 0.42785034 |
| 164 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41509682 |
| 165 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40721810 |
| 166 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40330506 |
| 167 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.39550089 |
| 168 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.38645112 |
| 169 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38333878 |
| 170 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36282589 |
| 171 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36243186 |
| 172 | Alcoholism_Homo sapiens_hsa05034 | 0.35799705 |
| 173 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34642757 |
| 174 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34487353 |
| 175 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33682062 |

